Skip to main content
Clinical Trials/NCT04304131
NCT04304131
Completed
Not Applicable

Colorectal Cancer Screening Using Stool DNA-based SDC2 Methylation Test

Kyung Hee University Hospital at Gangdong8 sites in 1 country1,210 target enrollmentJune 7, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Kyung Hee University Hospital at Gangdong
Enrollment
1210
Locations
8
Primary Endpoint
SDC2 methylation in stool DNA
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

A study of colorectal cancer screening using stool DNA-based SDC2 methylation test

Registry
clinicaltrials.gov
Start Date
June 7, 2020
End Date
January 10, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Suk-Hwan Lee

Professor

Kyung Hee University Hospital at Gangdong

Eligibility Criteria

Inclusion Criteria

  • Patient who agreed the clinical trial and signed informed consent
  • High risk patient for colorectal cancer (family history of colorectal cancer, history of adenomatous polyp excision, inflammatory bowel disease \> 15 years, or history of hereditary colorectal cancer)
  • Patient who scheduled to receive colonoscopy
  • Stool \> 20g before bowel preparation for colonoscopy

Exclusion Criteria

  • No high risk patient under 60 years
  • History of colorectal cancer
  • Stool \< 20g or sample after bowel preparation
  • Diarrhea or liquid stool which cannot be evaluated
  • Patient who is judged as not suitable for clinical trial including a psychiatric disorder by a physician

Outcomes

Primary Outcomes

SDC2 methylation in stool DNA

Time Frame: 1 year

positive ratio of SDC2 methylation

sensitivity and specificity of EarlyTect

Time Frame: 1 year

Study Sites (8)

Loading locations...

Similar Trials